Solid Biosciences Inc. (SLDB)
NASDAQ
Market Cap
$218.76M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
17 of 809
Rank in Industry
14 of 445
Largest Insider Buys in Sector
SLDB Stock Price History Chart
SLDB Stock Performance
About Solid Biosciences Inc.
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Solid Biosciences Inc.
Over the last 12 months, insiders at Solid Biosciences Inc. have bought $23.87M and sold $126,958 worth of Solid Biosciences Inc. stock.
On average, over the past 5 years, insiders at Solid Biosciences Inc. have bought $30.79M and sold $298,727 worth of stock each year.
Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC () — $320.64M. RA CAPITAL MANAGEMENT, L.P. () — $125M. Kahn Clare (director) — $8,442.
The last purchase of 1,100 shares for transaction amount of $8,442 was made by Kahn Clare (director) on 2024‑06‑07.
List of Insider Buy and Sell Transactions, Solid Biosciences Inc.
| 2024-06-07 | Kahn Clare | director | 1,100 0.0027% | $7.67 | $8,442 | -7.32% | ||
| 2024-05-02 | Sale | Ganot Ilan | director | 462 0.0012% | $10.33 | $4,772 | -21.85% | |
| 2024-01-29 | Sale | Ganot Ilan | director | 139 0.0007% | $7.99 | $1,111 | +19.79% | |
| 2024-01-11 | PERCEPTIVE ADVISORS LLC | 3.41M 12.2033% | $5.53 | $18.86M | +16.56% | |||
| 2024-01-11 | RA CAPITAL MANAGEMENT, L.P. | 904,160 3.235% | $5.53 | $5M | +16.56% | |||
| 2024-01-09 | Sale | Tan Kevin | CFO & Treasurer | 3,935 0.0194% | $8.20 | $32,267 | +11.22% | |
| 2024-01-03 | Sale | Ganot Ilan | director | 1,142 0.0052% | $5.30 | $6,052 | +57.67% | |
| 2023-12-04 | Sale | Cumbo Alexander | President and CEO | 11,757 0.0459% | $2.77 | $32,516 | +140.29% | |
| 2023-12-04 | Sale | Howton David T | Chief Operating Officer | 5,367 0.0211% | $2.78 | $14,920 | +140.29% | |
| 2023-12-04 | Sale | Marlowe Jennifer | CSO | 4,890 0.0191% | $2.77 | $13,525 | +140.29% | |
| 2023-12-04 | Sale | Hanrahan Jessie | Chief Regulatory Officer | 4,879 0.0191% | $2.78 | $13,562 | +140.29% | |
| 2023-12-04 | Sale | Herzich Paul | Chief Technology Officer | 2,968 0.0116% | $2.77 | $8,232 | +140.29% | |
| 2023-05-02 | Sale | Ganot Ilan | director | 487 0.0023% | $4.85 | $2,364 | +1.91% | |
| 2023-01-27 | Sale | Morris Carl Ashley | Chief Scientific Officer | 441 0.0022% | $7.49 | $3,303 | -36.78% | |
| 2023-01-27 | Sale | Ganot Ilan | director | 1,523 0.0076% | $7.49 | $11,407 | -36.78% | |
| 2022-03-14 | Sale | Morris Carl Ashley | Chief Scientific Officer | 11,269 0.0111% | $1.10 | $12,396 | -48.01% | |
| 2022-03-14 | Sale | Schneider Joel Solomon Zev | Chief Operating Officer | 15,232 0.0149% | $1.10 | $16,755 | -48.01% | |
| 2022-02-10 | Sale | Ganot Ilan | CEO & President | 463 0.0004% | $1.12 | $519 | -49.91% | |
| 2021-03-23 | PERCEPTIVE ADVISORS LLC | 5.22M 6.0993% | $5.75 | $30M | -53.72% | |||
| 2021-03-19 | RA CAPITAL MANAGEMENT, L.P. | 4.41M 4.8845% | $5.75 | $25.38M | -55.67% |
Insider Historical Profitability
<0.0001%
| PERCEPTIVE ADVISORS LLC | 6833539 18.2525% | $5.70 | 4 | 0 | <0.0001% | |
| RA CAPITAL MANAGEMENT, L.P. | 4192216 11.1975% | $5.70 | 2 | 0 | <0.0001% | |
| Cumbo Alexander | President and CEO | 17439 0.0466% | $5.70 | 0 | 1 | |
| Tan Kevin | CFO & Treasurer | 9308 0.0249% | $5.70 | 0 | 1 | |
| Ganot Ilan | director | 9507 0.0225% | $5.70 | 0 | 11 | |
| Howton David T | Chief Operating Officer | 7684 0.0205% | $5.70 | 0 | 1 | |
| Hanrahan Jessie | Chief Regulatory Officer | 6983 0.0187% | $5.70 | 0 | 1 | |
| Marlowe Jennifer | CSO | 6998 0.0187% | $5.70 | 0 | 1 | |
| Herzich Paul | Chief Technology Officer | 4270 0.0114% | $5.70 | 0 | 1 | |
| Kahn Clare | director | 1100 0.0029% | $5.70 | 1 | 0 | |
| Boxer Capital, LLC | 10 percent owner | 3473272 9.2771% | $5.70 | 0 | 3 | |
| Arnold Matthew Bennett | director | 3386293 9.0448% | $5.70 | 0 | 2 | |
| Shah Rajeev M. | director | 2689444 7.1835% | $5.70 | 1 | 0 | |
| Koppel Adam | director | 1989444 5.3138% | $5.70 | 1 | 0 | |
| Ziolkowski Jennifer Lynn | CFO, Treasurer & Asst. Secy | 335636 0.8965% | $5.70 | 0 | 2 | |
| Schneider Joel Solomon Zev | Chief Operating Officer | 251542 0.6719% | $5.70 | 0 | 5 | |
| Quiroz Jorge Armando | Chief Medical Officer | 228092 0.6092% | $5.70 | 0 | 2 | |
| HERSCHA LYNETTE | Chief Legal Officer | 160859 0.4297% | $5.70 | 0 | 1 | |
| Amorrortu Pedro Alvaro | Chief Operating Officer | 153746 0.4107% | $5.70 | 0 | 3 | |
| Morris Carl Ashley | Chief Scientific Officer | 19760 0.0528% | $5.70 | 0 | 5 | |
| Zarur Juan Andrey | director | 10189 0.0272% | $5.70 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Perceptive Advisors | $92M | 18 | 6.91M | +97.56% | +$45.43M | 0.06 | |
| RA Capital Management, L.P. | $57.68M | 11.28 | 4.33M | +26.39% | +$12.04M | 0.06 | |
| Bain Capital Life Sciences Investors Llc | $53.74M | 10.51 | 4.03M | +28.88% | +$12.04M | 5.4 | |
| Adage Capital Partners Gp L L C | $33.82M | 6.62 | 2.54M | New | +$33.82M | 0.06 | |
| Artal Group S A | $33.3M | 6.51 | 2.5M | +174.96% | +$21.19M | 0.18 | |
| Deerfield Management | $30.11M | 5.89 | 2.26M | New | +$30.11M | 0.58 | |
| Janus Henderson | $23.93M | 4.71 | 1.81M | New | +$23.93M | 0.01 | |
| Silverarc Capital Management Llc | $17.65M | 3.45 | 1.33M | +122.75% | +$9.73M | 5.2 | |
| The Vanguard Group | $16.58M | 3.24 | 1.24M | +283.93% | +$12.26M | <0.0001 | |
| FINEPOINT CAPITAL LP | $12.8M | 2.51 | 961,251 | 0% | +$0 | 2.32 | |
| Laurion Capital Management LP | $12.36M | 2.42 | 928,169 | 0% | +$0 | 0.35 | |
| Millennium Management LLC | $9.76M | 1.91 | 733,081 | New | +$9.76M | 0.01 | |
| Monashee Investment Management LLC | $8.26M | 1.62 | 620,000 | New | +$8.26M | 0.71 | |
| Walleye Capital | $7.68M | 1.5 | 576,267 | +362.64% | +$6.02M | 0.02 | |
| Invesco | $6.29M | 1.23 | 472,107 | New | +$6.29M | <0.01 | |
| Alyeska Investment Group L P | $5.52M | 1.08 | 414,615 | -34.94% | -$2.97M | 0.03 | |
| BlackRock | $4.09M | 0.8 | 307,066 | +169.13% | +$2.57M | <0.0001 | |
| Geode Capital Management | $3.17M | 0.62 | 237,673 | +154.19% | +$1.92M | <0.0001 | |
| Susquehanna International Group | $2.9M | 0.57 | 217,392 | +554.11% | +$2.45M | <0.01 | |
| Goldman Sachs | $2.71M | 0.53 | 203,748 | New | +$2.71M | <0.01 | |
| Qube Research & Technologies | $1.74M | 0.34 | 130,648 | New | +$1.74M | <0.01 | |
| Atom Investors Lp | $1.35M | 0.26 | 101,509 | New | +$1.35M | 0.17 | |
| Two Sigma | $1.16M | 0.23 | 87,388 | +134.93% | +$668,530.71 | <0.01 | |
| Jane Street Capital | $1.15M | 0.22 | 86,004 | New | +$1.15M | <0.01 | |
| State Street | $976,276.00 | 0.19 | 73,294 | +64.36% | +$382,283.97 | <0.0001 | |
| JPMorgan Chase | $936,090.00 | 0.18 | 70,277 | +52,739.85% | +$934,318.44 | <0.0001 | |
| Renaissance Technologies | $916,000.00 | 0.18 | 68,771 | +80.64% | +$408,910.73 | <0.01 | |
| Dimensional Fund Advisors | $872,993.00 | 0.17 | 65,540 | +31.21% | +$207,658.85 | <0.0001 | |
| Bridgeway Capital Management | $680,079.00 | 0.13 | 51,057 | 0% | +$0 | 0.01 | |
| Man Group Plc | $651,641.00 | 0.13 | 48,922 | New | +$651,641.00 | <0.01 | |
| Citigroup | $635,524.00 | 0.12 | 47,712 | New | +$635,524.00 | <0.01 | |
| Northern Trust | $558,215.00 | 0.11 | 41,908 | +48.31% | +$181,831.46 | <0.0001 | |
| Marathon Trading Investment Management Llc | $496,836.00 | 0.1 | 37,300 | New | +$496,836.00 | 0.2 | |
| Citadel Advisors LLC | $458,541.00 | 0.09 | 34,425 | New | +$458,541.00 | <0.0001 | |
| Bank of America | $404,409.00 | 0.08 | 30,361 | +666.89% | +$351,675.06 | <0.0001 | |
| American Century Investments | $329,057.00 | 0.06 | 24,704 | New | +$329,057.00 | <0.0001 | |
| ExodusPoint Capital Management, LP | $321,000.00 | 0.06 | 24,085 | New | +$321,000.00 | <0.01 | |
| Balyasny Asset Management Llc | $313,353.00 | 0.06 | 23,525 | New | +$313,353.00 | <0.01 | |
| Morgan Stanley | $295,507.00 | 0.06 | 22,185 | +424.1% | +$239,122.91 | <0.0001 | |
| Two Sigma Advisers LP | $193,140.00 | 0.04 | 14,500 | New | +$193,140.00 | <0.0001 | |
| UBS | $189,797.00 | 0.04 | 14,249 | +254.1% | +$136,197.23 | <0.0001 | |
| Raymond James Financial Services Advisors Inc | $176,610.00 | 0.04 | 13,259 | New | +$176,610.00 | <0.0001 | |
| Charles Schwab | $136,876.00 | 0.03 | 10,276 | New | +$136,876.00 | <0.0001 | |
| Barclays | $59,000.00 | 0.01 | 4,417 | 0% | +$0 | <0.0001 | |
| LAZARD ASSET MANAGEMENT LLC | $21,000.00 | <0.01 | 1,629 | New | +$21,000.00 | <0.0001 | |
| Macquarie Group | $17,000.00 | <0.01 | 1,267 | New | +$17,000.00 | <0.0001 | |
| Royal Bank of Canada | $1,000.00 | <0.01 | 66 | -97.84% | -$45,363.64 | <0.0001 | |
| First Manhattan Co. | $1,771.00 | <0.01 | 133 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $2,184.00 | <0.01 | 164 | +118.67% | +$1,185.22 | <0.0001 | |
| Advisor Group Holdings Inc | $399.00 | <0.01 | 30 | 0% | +$0 | <0.0001 |